antitumor vaccine derived from CD4 + normal chemically modified.

A method of preparing a composition of antigen presentation enriched CD4 + cells comprising stimulating proliferation of lymphoid cells inactivated normal using normal mature dendritic cells that have not been loaded with antigens to which should target the immune reaction to be inducing, and chemically treating the proliferating cells to agents that induce DNA demethylation or histone acetylation to induce expression of antigens of cancer / testis.